Efg Asset Management (North America) Corp. Twist Bioscience Corp Transaction History

Efg Asset Management (North America) Corp.

$585 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$26.2 - $54.0 $328,469 - $676,998	-12,537 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$38.58 - $83.27 $266,510 - $575,229	-6,908 Reduced 35.53%	12,537 $619,000
Q4 2021 Feb 18, 2022	BUY	$75.47 - $135.88 $1.47 Million - $2.64 Million	19,445 New	19,445 $1.51 Million

Others Institutions Holding TWST

# of Institutions

258

Shares Held

66.6M

Call Options Held

127K

Put Options Held

45.4K

Artisan Partners Limited Partnership Milwaukee, WI

6.02M
Shares

$289 Million
0.43% of portfolio
Vanguard Group Inc Valley Forge, PA

5.62M
Shares

$269 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.42M
Shares

$260 Million
0.01% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.36M
Shares

$257 Million
2.3% of portfolio
Invesco Ltd. Atlanta, GA

3.64M
Shares

$175 Million
0.03% of portfolio

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.7B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account